Stepwise Reversal of Immune Dysregulation Due to STAT1 Gain-of-Function Mutation Following Ruxolitinib Bridge Therapy and Transplantation
Başak Kayaoğlu, Nurhan Kasap, Naz Surucu Yilmaz, Louis‐Marie Charbonnier, Büsra Geckin, Arzu Akçay, Sevgi Bilgiç Eltan, Gülyüz Öztürk, Ahmet Özen, Elif Karakoç-Aydıner, Talal A. Chatila, Mayda Gürsel, Safa Barış
Topics & Concepts
RuxolitinibMedicineImmunologyHematopoietic stem cell transplantationImmune dysregulationTransplantationPrimary immunodeficiencyImmune systemInternal medicineBone marrowMyelofibrosisImmunodeficiency and Autoimmune DisordersPsoriasis: Treatment and PathogenesisCytokine Signaling Pathways and Interactions